The development of inflammatory bowel disease (IBU) is prevented by TNF-alpha blockade in HLA-B27+rats

被引：0
|
作者：
Milia, A. F. [1 ]
Manetti, M. [2 ]
Cinelli, M. [1 ]
Generini, S. [1 ]
Polidori, L. [2 ]
Beneli, G. [2 ]
Ibba-Manneschi, L. [2 ]
Matucci-Cerinic, M. [1 ]
机构：
[1] Univ Florence, Dept Internal Med, Rheumatol Sect, I-50121 Florence, Italy
[2] Univ Florence, Dept Anat Hystol & Foren Med, I-50121 Florence, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [31] THE ECONOMIC REASON FOR THE USE OF VEDOLIZUMAB COMPARED WITH INHIBITORS OF TNF-ALPHA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON THE EXAMPLE OF MOSCOW
    Kornilova, E.
    Poliakova, K.
    Ermolaeva, T.
    Davydovskaya, M.
    Ermolaeva, A.
    Fisun, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S422 - S422
  • [32] LACK OF ASSOCIATION OF HLA B27 WITH RADIOGRAPHIC SACROILIITIS IN INFLAMMATORY BOWEL-DISEASE
    HYLA, JF
    FRANCK, WA
    DAVIS, JS
    [J]. JOURNAL OF RHEUMATOLOGY, 1976, 3 (02) : 196 - 200
  • [33] Increased intestinal permeability and the effect of cyclosporin A in an experimental animal model or inflammatory bowel disease in HLA-B27 rats.
    Kerr, SW
    Wolyneic, W
    Filipovich, Z
    Braza, F
    Winquist, RJ
    Noonan, T
    [J]. FASEB JOURNAL, 1998, 12 (05): : A737 - A737
  • [34] CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF Treated Inflammatory Bowel Disease Patients: Clinical Feasibility & Perspectives
    Juillerat, Pascal
    Andrew, Peter M.
    Macpherson, James
    Slack, Emma
    Patuto, Nicola
    Cahenzli, Julia
    Seibold, Frank
    McCoy, Kathy D.
    Macpherson, Andrew J.
    [J]. SWISS MEDICAL WEEKLY, 2014, 144 : 3S - 3S
  • [35] CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF Treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives
    Juillerat, Pascal
    Andrew, Peter M.
    Macpherson, James
    Slack, Emma
    Cahenzli, Julia
    Seibold, Frank
    Mccoy, Kathy D.
    Macpherson, Andrew J.
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S239 - S239
  • [36] Anti-drug Antibodies Inhibit Neutralization of TNF-alpha in Infliximab Treated Patients with Inflammatory Bowel Disease (IBD)
    Eser, A.
    Vogelsang, H.
    Reinisch, S.
    Novacek, G.
    Dejaco, C.
    Kazemi-Shirazi, L.
    Primas, C.
    Lichtenberger, C.
    Brehovsky, S.
    Singh, S.
    Jain, A.
    Reinisch, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S304 - S305
  • [37] HISTOPATHOLOGIC FINDINGS IN INFLAMMATORY BOWEL-DISEASE IN HLA-B27 POSITIVE (REACTIVE) ARTHRITIS
    CUVELIER, C
    DEVOS, M
    MIELANTS, H
    ROELS, H
    VEYS, E
    [J]. JOURNAL OF PATHOLOGY, 1984, 143 (01): : A3 - A3
  • [38] Anterior uveitis, inflammatory bowel disease, and ankylosing spondylitis in a HLA-B27-positive woman
    Singleton, E. Mitchell
    Hutson, Sanford E.
    [J]. SOUTHERN MEDICAL JOURNAL, 2006, 99 (05) : 531 - 533
  • [39] PIGMENTED PURPURIC DERMATOSIS AFTER TNF-alpha INHIBITOR COMMENCEMENT FOR HLA B27 POSITIVE PERIPHERAL SPONDYLARTHRITIS: A CASE REPORT
    Jhaveri, Divita
    Zhao, Frances
    [J]. INTERNAL MEDICINE JOURNAL, 2021, 51 : 12 - 13
  • [40] THE GERM-FREE STATE PREVENTS DEVELOPMENT OF GUT AND JOINT INFLAMMATORY DISEASE IN HLA-B27 TRANSGENIC RATS
    TAUROG, JD
    RICHARDSON, JA
    CROFT, JT
    SIMMONS, WA
    ZHOU, M
    FERNANDEZSUEIRO, JL
    BALISH, E
    HAMMER, RE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (06): : 2359 - 2364
12345